UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003694 |
|---|---|
| Receipt number | R000004474 |
| Scientific Title | Effect of Vitamine D3 for the patients whith chronic hepatitis C who recieved PEG-interferon alpha plus ribavirin: possible applicaition for database establishment. |
| Date of disclosure of the study information | 2010/06/10 |
| Last modified on | 2021/03/12 14:22:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/06/02 10:58:56 | ||
| 2 | Update | 2010/10/21 11:46:49 | Name of person sending information Organization Division name Address |
|
| 3 | Update | 2010/10/21 11:47:41 | Recruitment status |
|
| 4 | Update | 2010/10/21 11:48:30 | Interventions/Control_1 Interventions/Control_1 |
|
| 5 | Update | 2010/12/02 09:21:57 | Last name of contact person Last name of contact person |
|
| 6 | Update | 2011/07/02 11:03:51 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 7 | Update | 2011/07/02 11:05:23 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 8 | Update | 2011/12/02 09:05:09 | TEL |
|
| 9 | Update | 2015/06/02 09:38:29 | Email Address Address |
|
| 10 | Update | 2015/06/02 09:40:20 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 11 | Update | 2015/12/02 17:05:04 | Recruitment status Publication of results URL related to results and publications Results |
|
| 12 | Update | 2017/09/11 13:02:38 | Name of primary person or sponsor Organization |
|
| 13 | Update | 2017/09/11 13:03:43 | Date of protocol fixation |
|
| 14 | Update | 2021/03/12 14:17:18 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 15 | Update | 2021/03/12 14:18:39 | Date of IRB |
|
| 16 | Update | 2021/03/12 14:22:17 | URL releasing protocol Publication of results Number of participants that the trial has enrolled Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
